24.11.2015
- Confirming rumors of the past weekend, US pharmaceutical giant Pfizer has said it will buy drugmaker Allergan for $160 million and move its headquarters to Ireland. The ever faster...
12.11.2015
- Standard & Poor’s and Moody’s have both lowered their credit ratings for Anglo-Swedish drugs company AstraZeneca. Citing a negative outlook from the loss of patent protection on...
08.11.2015
- Anglo-Swedish drugs firm AstraZeneca has unveiled plans to buy US biopharmaceutical company ZS Pharma, in a move that boosts its portfolio for treating cardiovascular and metabolic...
30.10.2015
- In what is being called a “landmark clinical trial” of genetic oncology, UK researchers have discovered that AstraZeneca’s Lynparza (olaparib), approved in 2015 to treat ovarian...
30.10.2015
- US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...
19.10.2015
- AstraZeneca’s US launch of a fixed-dose diabetes drug combination of saxagliptin and dapagliflozin has been delayed, due to concerns of the Food and Drug Administration (FDA). In a...
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
25.09.2015
- Following the green light from health regulator European Medicines Agency, the European Commission is expected to decide on a final approval for GlaxoSmithKline’s (GSK) injectable...
